Development and Validation of a Competitive Risk Model in Elderly Patients with Transitional Cell Bladder Carcinoma
Medical Science Monitor · 18.12.2024 · 31
DOI: 10.12659/msm.946332 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Medical Science Monitor, online erschienen am 18.12.2024. Verfasst von Libin Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University, N…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Carcinoma, Transitional Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Urology, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University, Ningbo, Zhejiang, China.
ORCID-Profile: Libin Yang, Chao Chen, Qianghui Wang, Tao Sun
Zitieren
APA
Yang, L., Chen, C., Wang, Q., Zhuang, Z., & Sun, T. (2024). Development and Validation of a Competitive Risk Model in Elderly Patients with Transitional Cell Bladder Carcinoma. Medical Science Monitor, 31. https://doi.org/10.12659/msm.946332
Vancouver
Yang L, Chen C, Wang Q, Zhuang Z, Sun T. Development and Validation of a Competitive Risk Model in Elderly Patients with Transitional Cell Bladder Carcinoma. Medical Science Monitor. 2024;31. doi:10.12659/msm.946332
BibTeX
@article{Yang2024,
author = {Yang, Libin and Chen, Chao and Wang, Qianghui and Zhuang, Zhiliang and Sun, Tao},
title = {Development and Validation of a Competitive Risk Model in Elderly Patients with Transitional Cell Bladder Carcinoma},
journal = {Medical Science Monitor},
year = {2024},
volume = {31},
doi = {10.12659/msm.946332}
}
EUVIMED